Taysha Gene Therapies, Inc.
USD7.04
+0.30 (+4.53%)
CEO
Sean Nolan
IPO Date
2020-09-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$6.79
Prev. Close
$6.73
Day Low
$6.74
Day High
$7.10
52W Low
$2.25
52W High
$7.30
Market Cap
$1.76B
Volume
1.97M
| -4.8 |
| 31 Dec 2023 | FY | 100.0% | -722.1% | -148.9% | -64.6% | 0.82 | 4.08 | -1.8 |
| 31 Dec 2022 | FY | 0.6% | -6635.3% | -17493.6% | -131.5% | 63.15 | 1.54 | -0.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -183.0% | -81.6% | 0.66 | 3.08 | -2.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -17.1% | -16.6% | 0.00 | 36.17 | -10.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 825.9% | -7433.3% | 0.00 | 0.10 | -798.2 |
| -15.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -14.9% | -10.3% | 0.32 | 10.48 | -8.8 |
| 30 Jun 2025 | Q2 | 100.0% | -1353.6% | -10.8% | -8.1% | 0.24 | 12.48 | -6.4 |
| 31 Mar 2025 | Q1 | 100.0% | -935.2% | -39.1% | -15.6% | 1.11 | 5.35 | -4.3 |
| 31 Dec 2024 | Q4 | 100.0% | -929.0% | -26.3% | -11.7% | 0.88 | 5.42 | -4.7 |
| 30 Sept 2024 | Q3 | 100.0% | -1427.5% | -28.7% | -14.2% | 0.70 | 5.51 | -5.3 |
| 30 Jun 2024 | Q2 | 100.0% | -1882.0% | -19.2% | -10.4% | 0.53 | 5.22 | -6.3 |
| 31 Mar 2024 | Q1 | 100.0% | -705.4% | -44.7% | -15.7% | 1.13 | 3.38 | -6.8 |
| 31 Dec 2023 | Q4 | 100.0% | 1324.7% | 63.7% | 27.6% | 0.82 | 4.08 | 1.7 |